{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-006449","form_type":"8-K","ticker":"ISCO","cik":"0001355790","company_name":"International Stem Cell CORP","filed_at":"2022-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:55.496579+00:00","generated_at":"2026-06-23T09:02:48.022733+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"CEO extends $2.9M loan maturity to March 2023 at 4.5% interest","bullets":["On Sep 15, 2022, International Stem Cell Corp. extended maturity of $2.9M loan from CEO Andrey Semechkin to Mar 15, 2023.","The loan originally issued Mar 1, 2022 was due Sep 15, 2022; replaced with new unsecured, non-convertible note.","Interest rate remains 4.5% per annum; company may prepay without penalty.","Dr. Semechkin is Co-Chairman and CEO; transaction is a related-party extension."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-006449","json":"https://secwatch.observer/filing/0001683168-22-006449.json","markdown":"https://secwatch.observer/filing/0001683168-22-006449.md","text":"https://secwatch.observer/filing/0001683168-22-006449.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1355790/000168316822006449/0001683168-22-006449-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1355790/000168316822006449/isco_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T09:02:48.022733+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}